Low-dose Cytosine arabinoside; disease free survival and overall survival in the elderly patients with Acute Myeloid Leukemia

Authors

  • zohreh Sanaat
  • Amin Najafi

Keywords:

Acute myeloid leukemia, Low-dose Cytosine arabinoside, Disease-free survival, Overall survival, Flowcytometry, Elderly AML.

Abstract

Objectives: The median age of the patients with acute myeloid leukemia (AML) is 65 years. Studies have revealed that the prognosis of the elderly patients (over 60 years) is not satisfying. The aim of this study was to evaluate the survival of AML patients being treated with Low-dose Cytosine arabinoside.
Methodology: In this cross-sectional study, 20 AML patients treated with Low-dose Cytosine arabinoside. Disease free survival and overall five-year survival ratios were identified.
Results: In this study there were 11 males (55%) and nine female (45%) with a mean age of 63.3

Downloads

Additional Files

Published

2011-12-10

How to Cite

Sanaat, zohreh, & Najafi, A. (2011). Low-dose Cytosine arabinoside; disease free survival and overall survival in the elderly patients with Acute Myeloid Leukemia. Pakistan Journal of Medical Sciences, 27(5). Retrieved from https://www.pjms.org.pk/index.php/pjms/article/view/17301

Issue

Vol. 27 No. 5 (2011): October - December 2011 Pak J Med Sci

Section

Brief Communication